Recent evidence and 2026 guidance (including NICE and Spanish reviews) show daily low-dose aspirin remains important for secondary prevention but is no longer routinely recommended for primary prevention because bleeding risks often outweigh modest cardiovascular benefits. Patients should not stop prescribed aspirin without medical advice; clinicia
